No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesia-Reference-Cited by-同舟云学术

No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesia

Published:2019-01 Issue:1 Volume:34 Page:e2685
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum Psychopharmacol Clin Exp

Author:

Levchenko Anastasia¹^ORCID,Vyalova Natalya²,Pozhidaev Ivan V.²,Boiko Anastasiia S.²,Osmanova Diana Z.²,Fedorenko Olga Yu.²³,Semke Arkadiy V.²,Bokhan Nikolay A.²⁴,Wilffert Bob⁵⁶,Loonen Anton J.M.⁵⁷,Ivanova Svetlana A.²³

Affiliation:

1. Institute of Translational Biomedicine; Saint Petersburg State University; Saint Petersburg Russia

2. Tomsk National Research Medical Center of the Russian Academy of Sciences; Mental Health Research Institute; Tomsk Russia

3. Division for Control and Diagnostics, School of Non-Destructive Testing & Security; National Research Tomsk Polytechnic University; Tomsk Russia

4. Department of Psychotherapy and Psychological Counseling; National Research Tomsk State University; Tomsk Russia

5. Unit of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy; University of Groningen; Groningen The Netherlands

6. Department of Clinical Pharmacy and Pharmacology; University Medical Center Groningen, University of Groningen; Groningen The Netherlands

7. GGZ Westelijk Noord-Brabant; Bergen op Zoom The Netherlands

Funder

Siberian Branch, Russian Academy of Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hup.2685/fullpdf

Reference36 articles.

1. Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia;Al Hadithy;Human Psychopharmacology,2010

2. Antipsychotic dose equivalents and dose-years: A standardized method for comparing exposure to different drugs;Andreasen;Biological Psychiatry,2010

3. Beyond cAMP: The regulation of Akt and GSK3 by dopamine receptors;Beaulieu;Frontiers in Molecular Neuroscience,2011

4. The physiology, signaling, and pharmacology of dopamine receptors;Beaulieu;Pharmacological Reviews,2011

5. Akt/GSK3 signaling in the action of psychotropic drugs;Beaulieu;Annual Review of Pharmacology and Toxicology,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies;Frontiers in Pharmacology;2022-01-24

2. A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2021-03

3. P.583 Polymorphisms in BDNF, AKT1, GSK3B genes: possible association with antipsychotic-induced hyperprolactinemia in schizophrenia patients;European Neuropsychopharmacology;2020-11

4. 5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia;Frontiers in Molecular Neuroscience;2020-04-24